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ARTICLE
Trait Components Provide Tools to Dissect the Genetic
Susceptibility of Migraine
V. Anttila, M. Kallela, G. Oswell, M. A. Kaunisto, D. R. Nyholt, E. Ha¨ma¨la¨inen, H. Havanka,
M. Ilmavirta, J. Terwilliger, E. Sobel, L. Peltonen, J. Kaprio, M. Fa¨rkkila¨, M. Wessman, and A. Palotie
The commonly used “end diagnosis” phenotype that is adopted in linkage and association studies of complex traits is
likely to represent an oversimplified model of the genetic background of a disease. This is also likely to be the case for
common types of migraine, for which no convincingly associated genetic variants have been reported. In headache
disorders, most genetic studies have used end diagnoses of the International Headache Society (IHS) classification as
phenotypes. Here, we introduce an alternative strategy; we use trait components—individual clinical symptoms of mi-
graine—to determine affection status in genomewide linkage analyses of migraine-affected families. We identified linkage
between several traits and markers on chromosome 4q24 (highest LOD score under locus heterogeneity [HLOD] 4.52),
a locus we previously reported to be linked to the end diagnosis migraine with aura. The pulsation trait identified a
novel locus on 17p13 (HLOD 4.65). Additionally, a trait combination phenotype (IHS full criteria) revealed a locus on
18q12 (HLOD 3.29), and the age at onset trait revealed a locus on 4q28 (HLOD 2.99). Furthermore, suggestive or nearly
suggestive evidence of linkage to four additional loci was observed with the traits phonophobia (10q22) and aggravation
by physical exercise (12q21, 15q14, and Xp21), and, interestingly, these loci have been linked to migraine in previous
studies. Our findings suggest that the use of symptom components of migraine instead of the end diagnosis provides a
useful tool in stratifying the sample for genetic studies.
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Migraine (MIM 157300) is the most common cause of
chronic episodic severe headache, affecting 10%–12% of
the adult population.1 The genetic component of migraine
has been well established in family and twin studies.2–6
Several loci linked to common forms of migraine with
significant evidence of linkage have been reported,7–15 yet,
to date, no genes responsible for susceptibility to the com-
mon types of migraine, migraine without aura (MO) and
migraine with aura (MA), have been described. Thus far,
three genes, CACNA1A (MIM 601011), ATP1A2 (MIM
182340), and SCN1A (MIM 182389), which contribute to
familial hemiplegic migraine (FHM1–3 [MIMs 141500,
602481, and 609634, respectively), a rare Mendelian sub-
type of MA, remain the only genes found in headache
disorders.16–18
Most studies aiming to unravel the genetic basis of head-
ache disorders use the end diagnoses of the International
Classification of Headache Disorders (later referred to as
“International Headache Society [IHS] classification”) as
the phenotype when monitoring for linkage or asso-
ciation19,20 (appendix A). Although diagnosis-based phe-
notypes have been successfully used to identify predis-
posing loci and even genes in some complex traits,21–23 it
is likely that they represent an oversimplified model of
the genetic background of a disease, which in reality is
complex and polygenic. In some complex diseases, the
use of clinical traits (referred to as “quantitative traits,”
“endophenotypes,” or “trait components”)—for example,
lipid values, components of language deficits, or allergy-
related phenotypes—provides an opportunity for a more
refined analysis.24–28 These traits probably reflect features
that are closer to the molecular background of the disorder
than the clinical classification, which represents a con-
sensus among clinicians. The development of alternative
phenotypes and/or endophenotypes would be especially
useful for headache disorders, for which diagnosis is typ-
ically based on the patient’s description of attacks and no
laboratory, radiological, or any other objective, quanti-
tative findings are used for diagnostics.
The diagnosis and classification of migraine and its sub-
types are based on the fulfillment of symptomatic criteria,
summarized in the IHS classification (appendixes B and
C). Since the migraine diagnosis consists of a combination
of traits and/or symptoms, a single affected individual has
to present with several traits simultaneously; furthermore,
the individual traits are not completely independent of
each other (fig. 1). The clinical traits and trait groups form-
ing the basis of the IHS classification provide a natural
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Figure 1. Schematic illustration of some relationships between
diagnoses and traits in the 2004 IHS classification. Overlapping
circles highlight the fact that each patient can have a unique
combination of symptoms, and not all symptoms are needed to
fulfill the criteria of the end diagnosis migraine. The circles and
their overlapping surface areas do not represent population prev-
alence; the figure serves purely as an illustration. a, Relationship
between MA and MO diagnostic groups indicating that some pa-
tients may be categorized as having purely MA type or purely MO
type of attacks, but a considerable number of patients have both
types. b, Relationships between traits in the IHS criteria, illus-
trating that, although criteria B–D are not shared by all patients
with MA, those with typical aura with migraine headache have to
fulfill the MO criteria as well. c, Breakdown of the vascular head-
ache trait group. The shaded area indicates patients who fulfill
IHS criteria C; at least two of the individual traits have to co-
occur (e.g., pulsation and unilaterality).
and clinically plausible way to monitor for possible trait
correlations. Although these criteria work well in clinical
settings, they still define a very broad syndrome. For ex-
ample, the criteria classify both a severe, one-sided, and
pulsating headache and a moderate, bilateral, and dull
headache as migraine, if the other IHS-defined features are
present. Allowance for variability is clearly needed for clin-
ical purposes, but a more narrow definition, especially one
that uses individual traits that can be quantified, might
serve better in dissecting the underlying pathophysiolog-
ical mechanisms of migraine. Since the use of one specific
trait, motor weakness, led to the discovery of genes caus-
ing FHM,18 a similar approach might be useful in more
common forms of migraine. A similar division of the fea-
tures of migrainous headache could contribute to the se-
lection of a more homogeneous study sample.
In summary, since migraine is a syndrome instead of a
clearly differentiated disease, we hypothesized that indi-
vidual clinical components of migraine (i.e., traits such as
pulsating pain and photophobia, among others) might
represent reflections of specific rather than shared loci and
thus independently contribute to susceptibility to mi-
graine. To test this hypothesis, the individual traits and
trait groups of the IHS criteria were used as phenotypes
for genomewide linkage analyses. These analyses were per-
formed using the same data set of 50 families as was used
in our previous study, in which evidence of linkage to
chromosome 4q24 was detected using end point diagnosis
MA as the trait.7 By use of the trait-based approach intro-
duced here, individuals from both the MA and the MO
diagnosis groups could potentially be scored as affected.
This reflects the sharing of the studied traits by migraine
diagnoses 1.1 (migraine without aura [appendix B]) and
1.2.1 (typical aura with migraine headaches [appendix C]).
Our hypothesis was that the shared components of the
two IHS diagnoses might result in migraine phenotypes
more reflective of the underlying biological processes than
would a strict adherence to the end diagnoses. Here, the
aim was to analyze which IHS traits provide best evidence
of linkage to the 4q24 locus and whether additional sus-
ceptibility loci could be localized.
Material and Methods
Diagnoses
The study sample consisted of 438 genotyped individuals (186
men and 252 women) in 50 independent, multigenerational
Finnish families and was the same set that was used in our pre-
vious genomewide screen.7 The ethics committee of Helsinki
University Central Hospital approved the study protocol. The in-
clusion criterion for the families selected for the previous ge-
nomewide screen was a high prevalence of MA within the family.
Various migraine features concerning the aura, headache, pro-
voking factors, and prodromal symptoms were recorded by one
neurologist (M.A.K.) on the basis of the validated Finnish Mi-
graine Specific Questionnaire for Family Studies.29 Detailed selec-
tion and case-definition procedures have been reported else-
where.7 In the previous study, 246 individuals received a diagnosis
of MA, and 50 individuals received a diagnosis of MO. In the
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Table 1. Frequencies of Individual Trait Components and Trait Groups
and the Sex Proportions of Those Affected, According to IHS Criteria,20
in the Study Sample
Trait or Trait Group
Corresponding to IHS Criteria n
Percentage
of Total
Percentage
Male
Percentage
Female
Full criteriaa: 225 52.3 26.2 73.8
Attack length 241 56.0 29.5 70.5
Vascular headache criteriaa: 322 74.9 33.9 66.1
Unilateral headache 327 76.0 34.3 65.7
Pulsating headache 235 54.7 27.2 72.8
Intensity, moderate and/or severe: 315 73.3 32.4 67.6
Unbearable 109 31.6 27.5 72.5
Severe 136 31.6 28.7 71.3
Moderate 70 16.3 47.1 52.9
Aggravated by physical activity 239 55.6 29.7 70.3
Associated symptomsa: 298 69.3 30.5 69.5
Nausea and/or vomitinga: 266 61.9 30.1 69.9
Nausea 266 61.9 30.1 69.9
Vomiting 173 40.2 31.8 68.2
Photo- and phonophobiaa: 229 53.3 25.8 74.2
Photophobia 265 61.6 30.6 69.4
Phonophobia 234 54.4 26.5 73.5
a A trait group.
present study, the updated IHS classification (2004) was used.
Under the new classification, 225 individuals fulfilled the IHS
criteria shared between MO (1.1 in the IHS diagnoses) and typical
aura with migraine headaches (1.2.1). This constitutes 49% of the
study sample.
Formation of Phenotypes from the Individual Traits and
Trait Groups
Altogether, nine individual traits (attack length, pulsation, uni-
laterality, aggravation by physical exercise, intensity of pain, pho-
tophobia, phonophobia, nausea, and vomiting) and five trait
groups (IHS full criteria, pain criteria, associated symptoms, nau-
sea and/or vomiting, and photo- and phonophobia) were ana-
lyzed independently as phenotypes in the linkage analysis. Table
1 summarizes the relative frequencies of the features of migrain-
ous headache in the study sample as reported by the patients,
defined by the IHS criteria, and used as traits in the analyses. The
important distinction between the individual traits and the trait
groups is that the individual traits reflect a distinct migraine fea-
ture, whereas the trait groups reflect a clinical consensus.
Since all individuals with vomiting also experienced nausea,
the nausea and the nausea and/or vomiting categories were equal,
and thus the nausea trait was not analyzed. In addition to the
IHS traits, we also used the age at onset of migraine symptoms
as a trait. Age was dichotomized to those individuals with the
onset of migraine symptoms before age 20 years (211 individuals)
and those with a later onset (64 individuals).
Genotyping
The process of the genomewide screen has been described in de-
tail elsewhere.7 Briefly, this screen covered all autosomes and the
X chromosome and used 350 polymorphic microsatellite mark-
ers, with an average of 11 cM between loci. In the fine-mapping
phase, 14 new microsatellite markers were analyzed (9 on chro-
mosome 17 and 5 on chromosome 18). For fine mapping, cap-
illary electrophoresis, as employed by the MegaBACE 1000 DNA
Sequencing System (GE Healthcare Bio-Sciences), was used to sep-
arate DNA fragments. Alleles were called by the MegaBACE Ge-
netic Profiler 1.5 software (GE Healthcare Bio-Sciences).
Linkage Analyses
Parametric and nonparametric LOD scores were calculated using
an affecteds-only strategy (i.e., all individuals not scored as af-
fected were considered as unknown) for the 350 markers geno-
typed. For parametric analysis, a dominant mode of inheritance
and locus heterogeneity was assumed. Each of the IHS traits and
trait groups were analyzed, in turn, as the phenotype. All analyses
were performed with the disease-gene frequency set at 0.001, un-
der the assumption of autosomal dominant inheritance and a
phenocopy proportion of 2.4%, reflecting the frequency of MA
in the population,7,30 in accordance with the strategy proposed
by Go¨ring and Terwilliger31 and in line with our previous research.
Allele frequencies were calculated from the genotypes of all in-
dividuals. The mistyping option of the SimWalk2 program32 was
used to detect genotyping errors. In case of bilineal family struc-
ture, the affected married-in spouse, as well as the offspring, were
treated as unknown. The initial linkage analysis was performed
using a two-point approach—that is, by using a single marker
and the trait. The components of the IHS migraine criteria were
used as the phenotype. Two-point parametric linkage analysis was
performed both under locus homogeneity and under locus het-
erogeneity by the computer programs LINKAGE33 and HOMOG.34
To lessen the dependence of our results on the assumption of a
dominance model, we also completed an affected sib pair (ASP)
analysis. The identity-by-descent (IBD) status of each ASP was
estimated using the program Sibpair, which favors a recessive
mode of inheritance. The ANALYZE utility program31 was used
to conduct these analyses. Multipoint parametric and nonpara-
metric analyses were performed for regions showing evidence of
linkage in the parametric two-point analysis by use of the pro-
gram GENEHUNTER,35 version 2.1_r5beta. Parametric linkage
analysis was performed using the model presented above, while
allowing for locus heterogeneity. The nonparametric statistic
88 The American Journal of Human Genetics Volume 79 July 2006 www.ajhg.org
Table 2. Correlation Matrix of the Analyzed Traits and Trait Groups
Trait a b c d e f g h i j k l m n
a 1.000 .944 .710 .623 .698 .639 .707 .773 .685 .685 .476 .658 .674 .663
b .944 1.000 .753 .620 .739 .649 .736 .706 .625 .625 .434 .604 .657 .623
c .710 .753 1.000 .737 .975 .747 .954 .884 .794 .794 .573 .706 .798 .720
d .623 .620 .737 1.000 .716 .720 .705 .716 .661 .661 .511 .646 .679 .643
e .698 .739 .975 .716 1.000 .734 .930 .882 .787 .787 .556 .701 .791 .714
f .639 .649 .747 .720 .734 1.000 .723 .700 .668 .668 .493 .596 .657 .601
g .707 .736 .954 .705 .930 .723 1.000 .879 .787 .787 .565 .710 .791 .724
h .773 .706 .884 .716 .882 .700 .879 1.000 .894 .894 .632 .784 .814 .784
i .685 .625 .794 .661 .787 .668 .787 .894 1.000 1.000 .707 .648 .695 .651
j .685 .625 .794 .661 .787 .668 .787 .894 1.000 1.000 .707 .648 .695 .651
k .476 .434 .573 .511 .556 .493 .565 .632 .707 .707 1.000 .481 .458 .490
l .658 .604 .706 .646 .701 .596 .710 .784 .648 .648 .481 1.000 .880 .982
m .674 .657 .798 .679 .791 .657 .791 .814 .695 .695 .458 .880 1.000 .860
n .663 .623 .720 .643 .714 .601 .724 .784 .651 .651 .490 .982 .860 1.000
NOTE.—Correlations were determined across individuals and are not dependent on relatedness of cases. Traits are as follows: a p
full criteria; bp attack length; cp vascular headache criteria; dp unilaterality; ep pulsation; fp pain intensity; gp aggravation
by physical exercise; hp associated symptoms; ip nausea and/or vomiting; jp nausea; kp vomiting; lp photo- and phonophobia;
m p photophobia; n p phonophobia.
NPLall, which estimates the statistical significance of alleles shared
IBD between all affected family members, was calculated also.
To address the multiple-testing issue and to determine the sig-
nificance of the results, we applied the equation introduced by
Kidd and Ott.36 They suggest that the lower limit of a significant
result in a genomewide scan is 3 plus the base 10 logarithm of
the number of independent tests performed. An addition of 0.3
to the significance limits is necessary to take into account the
extra df from the heterogeneity LOD (HLOD) calculation. Since
the traits we studied are not independent of each other, a cor-
relation matrix of the phenotypes was constructed (table 2), and
the software matSPD (see Web Resources) was used to calculate
the overall correlation coefficient to determine the equivalent
number of independent traits.37–39 This analysis showed that the
original 14 traits (where the one duplicate trait, nausea, is elim-
inated by the analysis) and trait combinations correspond to just
five independent variables; thus, the lower limit of significant
evidence of linkage is 4.00. That is, because of the high correlation
between the 14 traits, they behave statistically like five effectively
independent traits. Similarly, the lower limit of suggestive evi-
dence of linkage is 1.6 plus the base 10 logarithm of the number
of tests plus 0.3, which equals 2.60. These limits are only slightly
less conservative than the ones obtained using the most conser-
vative correction based on the number of tests. Finally, to further
determine the significance of the observed LOD scores, we sim-
ulated the marker with the best observed LOD score (D17S945)
in 10,000 replicates of the pedigree set, assuming no linkage and
using the program SIMULATE.40 The tested limits were the best
observed LOD score (4.65) and the approximations of the sig-
nificance limits (4.00 and 2.60). These three limits were reached
zero, zero, and five times by chance in the simulated data sets,
with the highest result 3.19, which is less conservative than our
significance limit obtained from the trait correlation matrix.
Results
Linkage to 13 migraine-related traits was analyzed in a
genomewide scan of 438 individuals from 50 migraine-
affected families enriched for MA. Significant evidence of
linkage was observed with the individual traits pulsation
(17p13), photophobia (4q24), phonophobia (4q24), and
age at onset (4q24) (fig. 2 and table 3). With the trait
combinations, suggestive evidence of linkage was ob-
served with photo- and phonophobia (4q24) and IHS full
criteria (18q12), a combination of the shared traits of di-
agnoses 1.1 and 1.2.1 of the IHS 2004 classification that
includes individuals classified with MA and/or MO as their
end diagnosis. Table 3 shows the significant and suggestive
two-point LOD scores found.
MA Locus on 4q24
Our previously reported and replicated MA locus on
4q247,15 showed significant evidence of linkage to pho-
tophobia (two-point HLOD 4.39) and phonophobia (4.10)
and suggestive evidence of linkage to pain intensity (3.71),
unilaterality (3.25), and pulsation (3.14) as well as the
photo- and phonophobia trait group (3.97) and the as-
sociated symptom trait group (2.98) (fig. 3a) with marker
D4S1647. With the trait photophobia, GeneHunter mul-
tipoint parametric (HLOD 2.05) and nonparametric (NPLall
4.13) analyses positioned the peak at 103 cM and 92 cM,
respectively (fig. 4a).
New Locus on 17p13.1
Significant evidence of linkage was found between the
pulsation trait and marker D17S945, where a two-point
HLOD score of 4.65 was detected (fig. 3b). This encour-
aging result triggered us to fine map the region with nine
additional markers, providing a map interval of 1.7 cM.
These markers supported the existence of a susceptibility
locus in this region. GeneHunter multipoint parametric
(HLOD 3.46) and nonparametric (NPLall 3.94) tests posi-
tioned the peak at 19.4 and 22.0 cM for the pulsation trait
(fig. 4b). Other IHS traits showed, at best, nearly suggestive
evidence of linkage to this locus, the highest of which was
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Figure 2. Results of the parametric two-point linkage analysis under heterogeneity for genomewide screen with the end diagnosis
MA, the trait components and trait groups, and age at onset used to determine affection status. The lower significance limits are 4.00
for significant evidence and 2.60 for suggestive evidence of linkage. Arrows denote markers with significant or suggestive results.
between the trait vomiting and marker D17S945 (HLOD
of 2.07).
Loci Providing Suggestive Evidence of Linkage
The second new locus was detected on 18q12.1 with
marker D18S877 (fig. 3c) and the IHS full criteria (two-
point HLOD 3.29). With this marker, individual traits
showed suggestive evidence of linkage, with vascular cri-
teria (3.14), attack length (3.00), and aggravation by phys-
ical exercise (2.77) showing the highest LOD scores. In
addition, vomiting and nausea showed nearly suggestive
evidence of linkage at this locus (HLOD 2.66). Neither of
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the adjacent markers of the 10-cM marker set (D18S453,
12 cM proximal, and D18S535, 11.5 cM distal) provided
supportive evidence of linkage with any trait. In spite of
this, we decided to fine map this locus with five additional
markers, providing a map interval of 3.2 cM. Two markers
supported a locus in this region, with suggestive (D18S56
and aggravation by physical exercise) and nominal
(D18S1107 and attack length) evidence of linkage. Gene-
Hunter multipoint parametric analysis positioned the
peak at 50.0 cM, with an HLOD of 1.53 (fig. 4c) with the
IHS full criteria. At this position, however, the NPLall score
was 3.40 (at 51.0 cM), suggesting that perhaps the para-
metric dominant model was not a good fit for this trait.
By use of the ASP method and the IHS full criteria, marker
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Table 3. Locations and Two-Point LOD Scores for Traits or Trait Groups
Providing a LOD Score 12.60 in the Genomewide Screen in at Least One
Analysis
Marker (Location)
and Trait or Trait Group
Results
under Locus
Homogeneity
Results
under Locus
Heterogeneity
ASP
Analysis
LOD
Score
LOD
Score P
LOD
Score P
D4S2380 (4q22):
Age at onset 1.86 .001713 1.96 .005482 2.93
D4S1647 (4q24):
Age at onset 4.53 .000002 4.53 .000015 4.02
Photophobia 4.39 .000003 4.39 .000020 2.20
Phonophobia 4.10 .000007 4.10 .000040 2.81
Photo- and phonophobiaa 3.97 .000010 3.97 .000054 2.76
Intensity 3.71 .000018 3.71 .000097 2.60
Unilaterality 3.25 .000055 3.25 .000281 2.88
Pulsation 3.13 .000073 3.14 .000362 3.49
Vascular headachea 3.09 .000081 3.09 .000406 2.30
Associated symptomsa 2.98 .000106 2.98 .000524 2.28
Nausea 2.46 .000382 2.46 .001734 3.28
Vomiting and/or nauseaa 2.46 .000382 2.46 .001734 3.28
Attack length 1.18 .009874 1.24 .028772 2.61
D4S2394 (4q28):
Age at onset 2.99 .000233 2.99 .001094 .25
D4S1520 (4q31):
Phonophobia 2.66 .000257 2.66 .001199 .82
Photo- and phonophobiaa 2.62 .000257 2.62 .001199 1.06
D17S945 (17p13):
Pulsation 4.65 .000002 4.65 .000011 .82
D18S877 (18q12):
IHS full criteriaa 1.06 .013573 3.29 .000256 .26
Vascular headachea .92 .019779 3.14 .000362 .42
Attack length .95 .018236 3.00 .000500 .09
Aggravation by physical exercise 1.24 .008432 2.77 .000849 .03
D18S862 (18q21):
Aggravation by physical exercise 1.75 .002264 2.69 .001021 1.21
D18S1364 (18q22):
IHS full criteriaa .03 .364661 .17 .338041 3.04
Attack length .18 .181291 .29 .256431 2.71
a A trait group.
D18S1102, 8 cM distal of the parametric two-point HLOD
peak, provided an ASP LOD score of 3.04. Adjacent mark-
ers D18S56 and D18S535 provided ASP LOD scores of 1.72
and 2.20, respectively.
In addition to the locus on 4q24, a second region on
4q, 4q28-q31, indicated suggestive evidence of linkage
with multiple traits and age at onset. Among the traits,
the highest evidence of linkage was observed between
marker D4S1520 and the traits phonophobia (HLOD 2.66)
and photo- and phonophobia (HLOD 2.62). Furthermore,
several markers around marker D4S1520 showed nearly
suggestive evidence of linkage with the same traits.
Loci Providing Nominal Evidence of Linkage
In addition to the chromosomal loci on 4q24, 4q28,
17p13, and 18q12, four other loci with nearly suggestive
evidence of linkage were observed on 10q22, 12q21,
15q14, and Xp21. Marker D10S2327 produced a two-point
HLOD score of 2.27 with phonophobia. On chromosome
12q21, marker D12S1064 produced an HLOD score of 2.17
with the aggravation by physical exercise trait. However,
none of the surrounding markers supported linkage to
these loci. On 15q14, aggravation by physical exercise pro-
duced a two-point HLOD score of 2.14 with marker ACTC.
On Xp21, aggravation by physical exercise produced an
HLOD of 1.92, associated symptoms an HLOD of 1.91,
and unilaterality an HLOD of 1.90 with marker DXS9896.
At these two loci, a number of adjacent markers also pro-
vided nominal evidence of linkage to several traits (three
for 15q14 and seven for Xp21).
Age at Onset
In addition to the IHS traits, we analyzed the age at onset
of migraine as a trait. Age was dichotomized to consider
those patients whose migraine symptoms began before
age 20 years as affected and the others as unknown. The
analysis showed a significant two-point HLOD score of
4.52 at 4q24 (D4S1647). One other marker (D4S2394) with
Figure 3. Parametric two-point HLOD scores for chromosome 4 (a), chromosome 17 (b), and chromosome 18 (c) for all trait components
and age at onset.
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suggestive evidence of linkage was found, on 4q28 (HLOD
2.99), with adjacent markers providing nearly suggestive
evidence of linkage, corroborating the second locus on
chromosome 4. In analyzing for late onset (at age 120
years), no markers showed evidence of linkage reaching
the suggestive level.
Stratification by Sex
In a study of migraine in the Icelandic population,15 link-
age results were improved considerably when the sexes
were analyzed separately. Thus, we analyzed the data by
treating all females and males, in turn, as unknown for
all traits for the chromosomes yielding suggestive or sig-
nificant results. On the 4q24 locus, no significant differ-
ences between the sexes were found. At the 17p13 locus,
the pulsation trait showed a two-point HLOD score of 2.02
for females ( ) and 2.72 for males ( ). At thisnp 174 np 67
locus, no other trait exceeded that score in males, but the
intensity trait reached a LOD score of 2.34 in females. On
the 18q12 locus, the IHS full criteria produced a nearly
significant two-point LOD score of 3.79 for females (np
) but a LOD of only 1.95 for males ( ). At this167 np 63
locus, several other traits produced suggestive results (in
males, 3.41 for the pain criteria, 3.11 for nausea, and 2.92
for intensity; in females, 2.76 for photophobia), but, with
all traits, the sex difference was smaller than the one ob-
served with IHS full criteria. In addition, attack length
produced a LOD score of 3.35 in females and 3.23 in males.
No other significant differences between the sex-specific
phenotypes were found for the two loci.
Discussion
Although introduction of the IHS criteria has done much
to ease the diagnostics of migraine disorders and has had
a major impact on clinical trials and epidemiological re-
search in this field, none of the features occur in all pa-
tients who meet a strict definition of IHS migraine, and
no single symptom is required for diagnosis. In other
words, although there is considerable correlation between
individual symptoms (table 2), migraine is a symptom
complex with variable symptom profiles, and individuals
presenting with dissimilar symptoms can equally satisfy
the same diagnosis (appendixes B and C). In fact, contro-
versy exists about whether MO and MA are actually two
separate entities.41,42 Furthermore, some individuals may
not completely satisfy the IHS criteria but are nonetheless
considered affected in a clinical setting. We therefore hy-
pothesized that examination of individual symptoms and
their subgroupings (i.e., trait components) would provide
considerably greater power than use of the IHS end diag-
nosis to identify genes underlying migraine susceptibility.
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Figure 4. Multipoint parametric HLOD scores (solid lines) and nonparametric NPLall scores (dotted lines) for chromosome 4 and phono-
phobia (a), chromosome 17 and pulsation (b), and chromosome 18 and IHS full criteria (c).
The trait-component analysis identified several traits
that also show linkage to the previously reported MA locus
on chromosome 4q24. Interestingly, the restratification
revealed one novel locus (17p13) with significant evidence
of linkage to the pulsation trait and two other loci with
suggestive evidence of linkage to the traits age at onset
(4q28) and IHS full criteria (18q12).
These findings suggest that dissecting the end diagnosis
into intermediate phenotypes and/or traits might help to
dissect the genetic basis of headache disorders and thus
help to stratify study samples into less heterogeneous
groups. Here, we were able to identify new loci to which
only a subset of migraine-associated symptoms were
linked. This supports the well-accepted hypothesis in com-
plex traits that specific gene variants in different loci
contribute in different combinations to the individual
susceptibility.43,44 However, this can be verified and further
studied only after specific alleles within these loci have
been identified. Trait-based approaches have been used in
several complex traits, such as asthma,45 schizophrenia,46
autism,26 and hyperlipidemias.27 The migraine end diag-
nosis is composed of a number of possibly biologically
diverse components; thus, it is plausible to hypothesize
different biological processes behind these components.
Also, migraine has a distinct set of diagnostic criteria that
provide a good starting point for this type of analy-
sis.19,20 In addition, some biochemical evidence for such
an approach has been found in another common primary
headache disorder. In tension-type headache, patients
with the pulsating subtype seem to have higher calcitonin
gene–related peptide levels than those of patients with
nonpulsating headache.47
Prompted by the differences in the results of the linkage
analysis between individual traits and the end diagnosis
MA,7 we analyzed the differences between the affection
groups contributing to the peaks at 17p13 and 18q12. Of
the individuals in the set pointing to the locus at 17p13,
there were 66 individuals with pulsating headache who
were coded as unknown in the original study, either be-
cause of their lack of aura symptoms or because the mi-
graine was inherited in a bilineal fashion. Conversely,
there were 51 individuals with nonpulsating headache
who were coded as affected in the original study. Com-
bined, this means a total difference of 49.7% (117 of 235)
in the pulsation group classified as affected in this study
compared with our previous genomewide scan. Similarly,
there were 62 affected individuals in the set pointing to
the 18q12 locus who were coded as unaffected in the pre-
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vious study because of a non-MA diagnosis or bilineal fam-
ily structure and, conversely, 61 individuals who did not
fulfill the full shared IHS criteria who were coded as af-
fected in the original study. This resulted in a 52% (123
of 225) combined difference between the group showing
the 18q12 locus and the end diagnosis group.7 Most of
the difference between these groups is the result of the
addition of patients with MO fulfilling the IHS full criteria.
In contrast, from the total of 246 individuals with MA, 62
had an attack length of !4 or 172 h. This causes them to
fall outside of the 1.2.1 (typical aura with migraine head-
ache) diagnostic group, which is new to the IHS 2004
classification. One could speculate that the change in the
classification eliminated excess heterogeneity from the
MA group and thus revealed the 18q12 locus.
It is likely that analyzing the trait components of head-
ache is feasible only in highly selected samples—for ex-
ample, in the present study, in which families with a high
incidence of IHS migraine were considered. For instance,
if a gene for pulsating headache exists, it will most likely
be a small component of the total genetic load that pre-
disposes a patient to the migraine syndrome. In the gen-
eral population, the coexistence of this pulsating factor
and other contributing factors is likely to be rare, but, in
study samples already enriched for the presence of mi-
graine, both elements may have a chance to co-occur and
predispose the patients in the family to a migraine head-
ache that pulsates (“beats with the heart”). Thus, as for
other complex traits, the highly selected families with mi-
graine may be better for identifying some migraine sus-
ceptibility genes and thus make identification of those
genes a realistic goal. This, in the end, could even help to
validate the clinical decisions that form the basis of the
current migraine criteria.
It is interesting that, even though several traits provided
evidence of linkage at the same locus, individual traits
within the main IHS categories provided evidence of link-
age at different loci. For example, the traits in the asso-
ciated-symptoms category (nausea and/or vomiting and
photo- and phonophobia) provided evidence of linkage
at different loci; vomiting and nausea showed nearly sug-
gestive evidence of linkage on chromosome 18q12, and
photo- and phonophobia on chromosome 4q24. Simi-
larly, intensity and pulsation, both traits of the vascular
headache criteria, provided evidence of linkage on differ-
ent chromosomes: 4q24 and 17p13, respectively. This
could suggest that, even if the grouping of IHS symptoms
is logical and practical in clinical practice, it may not re-
flect the genetic background of the susceptibility of in-
dividual traits. This is not very surprising in light of what
is known about the heterogeneity of the clinical findings
in Mendelian forms of migraine. In FHM-affected families,
family members with the same underlying mutation can
have different phenotypes, ranging from severe hemiple-
gic symptoms to MO to having no migraine at all.18 In
other complex traits, the idea of using subgroups of clin-
ical classifications (e.g., DSM-IV in schizophrenia) is under
active study, even though the approach has yet to provide
support for stratifying the sample for susceptibility clas-
sification. However, much of the trait relationship be-
tween susceptibility loci remains speculative as long as
the underlying allelic variants are not identified; because
the linkage information is provided by relatively few mei-
oses, there is a possibility that some of these trait differ-
ences weaken or disappear once association analyses are
performed.
In further analyses, it was found that, at the 18q12 locus,
a few large families provided clearly negative LOD scores
(three families had LOD scores ranging from 1.65 to
2.17), likely contributing to the large difference between
the LOD scores under locus homo- and heterogeneity. By
analyzing the data without those families, the difference
between the scores decreases considerably, with the ho-
mogeneity LOD score rising closer to the level of the
HLOD score. We also observed a large difference between
the sex-specific LOD scores, with a considerably higher
female score. The reason for this difference is not clear, as
it might reflect a true sex difference at this locus or merely
follow from the smaller sample size of males. The sex-
specific analysis is a relevant option in migraine because
of the high difference in prevalence between the sexes.1
At present, several loci, 4q21-q24,7,15 5q21,11 6p12.2-
p21.1,14 11q24,8 14q21.2-q22.3,13 and 15q11-q13,9 with
significant evidence of linkage to common forms of mi-
graine have been reported, with only the chromosome
4q21-q24 region detected in two independent studies. In-
terestingly, the most significant new locus identified in
this study, on 17p13, has shown nominal evidence of link-
age both in our previous study7 and in an Australian
study.10 It remains to be seen whether this locus harbors
a specific variant(s) contributing to the sensation of pul-
sating pain. Our results also seem to corroborate several
other previous findings. The locus on 18q12 has been im-
plicated in an Icelandic study,15 in which the same marker
(D18S877) gave a LOD score of 1.50. That study was con-
ducted using 103 families with MO-affected members,
which ties well with our approach and results. Also, a
marker 13 cM away (D18S53) gave a LOD score of 2.30 in
an Australian study.10 The general observation in migraine,
for which different studies provide different loci, is typ-
ical for complex traits for which finding a causative var-
iation has proven difficult, such as hypertension25 and
schizophrenia.48
Furthermore, it is interesting to note that several of our
findings agree with those from an empirical clustering ap-
proach called “latent class analysis” (LCA), introduced in
a recent article by Nyholt et al.49 and applied to migraine
symptom data in genome scans in two separate collections
of migraine-affected Australian families.10,11 LCA is a sta-
tistical method, closely analogous to cluster analysis, for
finding subtypes of related individuals (latent classes)
from multivariate categorical data.50 Briefly, a latent class
cluster model describes the relationship between a set of
observed variables and an unobserved, latent variable. The
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Table 4. Results of Previous Genomewide Scans in Migraine with Suggestive or Significant LOD Scores
and the Corresponding Results of the Present Study
Chromosomal
Arm
Study
Reference Studied Phenotype Marker
LOD
Score
LOD Score
in This
Study Trait in This Study
3q 10 LCA-severea D3S1311 2.28b 1.23 Intensity
4q 15 Loose MOc D4S1534 2.87b 2.00 Pulsation
4q 15 Females-only loose MOc D4S2409 4.08b 2.00 Pulsation
4q 7 MA D4S1647 4.20d 4.53 Age at onset
5q 11 LCA-severea D5S2501 3.03b .03 Intensity
6p 14 MA and MO D6S452 5.41d .83 Vomiting
10q 11 LCA-severea D10S2327 2.32b 2.27 Phonophobia
11q 8 MA D11S4464 4.24d .53 Nausea and/or vomiting
14q 13 MO D14S978 3.70d .18 Attack length
18p 10 LCA-severea D18S53 2.30b .15 Aggravation by physical exercise
18q …e MA and MO D18S877 … 3.43 IHS full criteria
a LCA refers to latent class analysis, as presented elsewhere.49
b Nonparametric multipoint results.
c Refers to a reduced end diagnosis; in the study,15 it included patients who did not fulfill either vascular headache criteria
or associated symptom criteria of the IHS classification.
d Parametric two-point results.
e A marker in the present study, with a distance of 13 cM to the D18S53 marker in the study by Lea et al.10
categories of this latent variable are called “latent classes,”
or clusters. Therefore, LCA groupings consist of individ-
uals with different numbers and combinations of symp-
toms and thus reflect a measure of severity, different from
the traditional end point diagnosis based on strict IHS
diagnostic criteria and also different from the individual-
trait analysis used here. The LCA approaches migraine
from a different viewpoint than does our trait-component
analysis, as the LCA classes are, in effect, new classifica-
tions combining features from both end diagnosis and
trait components, formed on the basis of heritability es-
timates. The important point, however, with respect to
our approach, is that the LCA analysis49 named a typical
trait most correlated with each class in a manner ap-
proaching the present analysis, and it is interesting to note
that several results from these two analyses agreed with
each other.
Interestingly, the Australian LCA study of twins11 im-
plicated a locus on 10q22 (nonparametric multipoint LOD
score of 2.13), which was attained with marker D10S2327,
which also gave a two-point LOD score of 2.78 in this
study. They also reported this marker to be “most asso-
ciated with phonophobia and photophobia,”11(p.500) and it
is intriguing that the same marker and same clinical trait
produce suggestive results in two different populations.
Our 12q21 peak marker D12S1064 had a nominal LOD
score of 0.74 in our previous study,7 which also reported
the Xp21 peak marker DXS9896 (LOD 1.08). Marker ACTC
on chromosome 15 lies next to a genomic region con-
taining three GABA receptor genes that were linked to
migraine in an Italian study of 10 families with MA.9 As
can be expected, many loci reported in other studies (table
4) did not show evidence of linkage beyond the nominal
level. Similarly, no linkage to the FHM1,18 FHM2,16 and
FHM317 loci on chromosomes 19p13, 1q23, and 2q24 was
found in this study. Traits with the highest evidence of
linkage at these loci were age at onset (LOD score 0.53),
photo- and phonophobia (0.93), and photophobia (0.62),
for the FHM1, FHM2, and FHM3 loci, respectively. In our
earlier 2002 study, none of the three loci showed evidence
of linkage.7 The newly identified regions contain several
counterparts to the known FHM genes. Other interest-
ing candidates for additional research include genes par-
ticipating in energy metabolism and neurotransmitter
release.
Further studies performed with these traits are needed
to confirm whether trait analysis can reclassify patients
into more-homogeneous groups. The findings here sug-
gest that trait information collected to establish the IHS-
based diagnosis can provide an additional tool for strati-
fying a migraine study sample. This should be applicable
not only to family studies but also to case-control studies.
It is hoped that subsequent studies will confirm the va-
lidity of this approach.
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Appendix A
Migraine Subtypes According to the International Clas-
sification of Headache Disorders, 2nd Edition, 200420
1.1 Migraine without aura
1.2 Migraine with aura
1.2.1 Typical aura with migraine headache
1.2.2 Typical aura with nonmigraine headache
1.2.3 Typical aura without headache
1.2.4 Familial hemiplegic migraine
1.2.5 Sporadic hemiplegic migraine
1.2.6 Basilar-type migraine
1.3 Childhood periodic syndromes that are commonly
precursors of migraine
1.3.1 Cyclical vomiting
1.3.2 Abdominal migraine
1.3.3 Benign paroxysmal vertigo of childhood
1.4 Retinal migraine
1.5 Complications of migraine
1.5.1 Chronic migraine
1.5.2 Status migrainosus
1.5.3 Persistent aura without infarction
1.5.4 Migrainous infarction
1.5.5 Migraine-triggered seizure
1.6 Probable migraine
1.6.1 Probable migraine without aura
1.6.2 Probable migraine with aura
1.6.3 Probable chronic migraine
Appendix B
IHS Criteria for Migraine without Aura, 1988 and 200419,20
1.1 Migraine without aura
A. At least five attacks fulfilling criteria B–D
B. Headache attacks lasting 4–72 h (untreated or un-
successfully treated)
C. Headache has at least two of the following charac-
teristics:
1. Unilateral location
2. Pulsating quality
3. Moderate or severe intensity (inhibits or prohibits
daily activities)
4. Aggravation by walking stairs or similar routine
physical activity
D. During headache, at least one of the following:
1. Nausea and/or vomiting
2. Photophobia and phonophobia
E. At least one of the following:
1. History, physical- and neurological examinations
do not suggest secondary cause of headache
2. History, physical- and neurological examinations
do suggest such disorder, but it is ruled out by
appropriate investigations
3. Such disorder is present, but migraine attacks do
not occur for the first time in close temporal re-
lation to the disorder
Appendix C
Comparison of the Criteria for IHS Diagnoses 1.2 Migraine
with Aura of the 1988 Classification and the New 1.2.1
Typical Aura with Migraine Headache of the 2004
Classification
1.2 Migraine with aura (1988)
A. At least two attacks fulfilling criterion B
B. At least three of the following four characteristics:
1. One or more fully reversible aura symptoms in-
dicating focal cerebral cortical and/or brain stem
dysfunction
2. At least one aura symptom develops gradually over
14 min, or 2 symptoms occur in succession
3. No aura symptom lasts 160 min. If more than
one aura symptom is present, accepted duration
is proportionally increased
4. Headache follows aura with a free interval of !60
min (it may also begin before or simultaneously
with the aura)
C. At least one of the following:
1. History, physical- and neurological examinations
do not suggest secondary cause of headache
2. History, physical- and neurological examinations
do suggest such disorder, but it is ruled out by
appropriate investigations
3. Such disorder is present, but migraine attacks do
not occur for the first time in close temporal re-
lation to the disorder
1.2.1 Typical aura with migraine headache (2004)
A. At least two attacks fulfilling criteria B–D
B. Aura consisting of at least one of the following, but
no motor weakness:
1. Fully reversible visual symptoms including pos-
itive features (e.g., flickering lights, spots, or
lines) and/or negative features (i.e., loss of vision)
2. Fully reversible sensory symptoms including pos-
itive features (i.e., pins and needles) and/or neg-
ative features (i.e., numbness)
3. Fully reversible dysphasic speech disturbance
C. At least two of the following:
1. Homonymous visual symptoms (note: additional
loss or blurring of central vision may occur) and/
or unilateral sensory symptoms
2. At least one aura symptom develops gradually
over 5 min, and/or different aura symptoms
occur in succession over 5 min
3. Each symptom lasts 5 and 60 min
D. Headache fulfilling criteria B–D for 1.1 Migraine with-
out aura begins during the aura or follows aura within
60 min
E. Not attributed to another disorder (note: history and
physical and neurological examinations do not sug-
98 The American Journal of Human Genetics Volume 79 July 2006 www.ajhg.org
gest any of the disorders listed in groups 5–12, or
history and/or physical and/or neurological exami-
nations do suggest such disorder but it is ruled out
by appropriate investigations, or such disorder is pre-
sent but attacks do not occur for the first time in close
temporal relation to the disorder)
Web Resources
The URLs for data presented herein are as follows:
matSpD, http://genepi.qimr.edu.au/general/daleN/matSpD/
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi
.nlm.nih.gov/Omim/ (for migraine, CACNA1A, ATP1A2, SCN1A,
FHM1, FHM2, and FHM3)
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